WallStSmart
AYTU

Aytu BioScience Inc

NASDAQ: AYTU · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$2.58
+2.38% today

Updated 2026-04-30

Market cap
$27.05M
P/E ratio
P/S ratio
0.43x
EPS (TTM)
$-3.44
Dividend yield
52W range
$1 – $3
Volume
0.0M

Aytu BioScience Inc (AYTU) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item2007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-27916.00$-44799.00$-46631.00$-43375.00$-64818.00$-37849.00$-37704.00$-5.50M$-6.63M$-10.66M$-13.83M$-15.94M$-13.83M$-28.37M$-25.96M$-28.82M$-5.13M$-1.39M$-1.94M
Capital expenditures$0.00$7466.00$0.00$6576.00$0.00$0.00$8920.00$9298.00$252932.00$2.25M$111608.00$74707.00$59848.00$5.85M$2.34M$2.34M$0.00$329000.00$3.23M
Depreciation
Stock-based comp$60000.00$317000.00$500000.00$1.02M$902946.00$2.50M$348515.00$1.02M$1.08M$3.57M$5.25M$6.05M$2.37M$576000.00
Free cash flow$-27916.00$-52265.00$-46631.00$-49951.00$-64818.00$-37849.00$-46624.00$-5.51M$-6.89M$-12.91M$-13.94M$-16.02M$-13.89M$-34.22M$-28.30M$-31.16M$-5.13M$-1.72M$-5.17M
Investing cash flow
Financing cash flow
Dividends paid$27476.00
Share repurchases
Debt repayment
Net change in cash$1753.00$4.71M$701129.00$-7.18M$6.23M$4.18M$37.04M